A Case Of Drug Reemergence: The Artificial Cannabinoid, 5f-adbThe DEA proposes rescheduling FDA-approved products containing marijuana from Schedule I to Schedule III, potentially 5f-adb liquid easing entry for clinicians and patients whereas sustaining federal management. SCRAs belong, together with artificial opioids, cathinones, amphetamines and hallucinogens to the brand new psychoactive
